NCT06465069 A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors Status RECRUITING Phase PHASE1
NCT06443944 An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG Status AVAILABLE Phase N/A
NCT06427993 Urine DNA Methylation Detection for Hematuria Evaluation Status NOT_YET_RECRUITING Phase N/A
NCT06427824 Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy Status RECRUITING Phase NA
NCT06427291 Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients Status RECRUITING Phase PHASE1
NCT06422312 A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients. Status WITHDRAWN Phase NA
NCT06416319 Preoperative Physical Activity Improvement With the Use of Activity Trackers Before Radical Cystectomy (PreAct) Status RECRUITING Phase NA
NCT06408597 Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy Status ACTIVE_NOT_RECRUITING Phase NA
NCT06397040 The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy Status COMPLETED Phase NA
NCT06394570 Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06390111 A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. Status WITHDRAWN Phase PHASE4
NCT06389019 Whole-slide Image and CT Radiomics Based Deep Learning System for Prognostication Prediction in Bladder Cancer Status RECRUITING Phase N/A
NCT06388720 The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy Status RECRUITING Phase PHASE2
NCT06381895 The Efficacy of Radiomics to Predict Tumor Microenvironment Markers and Comprehensive Therapy for Bladder Cancer Status COMPLETED Phase N/A
NCT06374914 Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients Status NOT_YET_RECRUITING Phase N/A
NCT06364956 Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT06364904 A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma. Status NOT_YET_RECRUITING Phase PHASE3